Johnson and Johnson Newswire

Comprehensive Real-Time News Feed for Johnson and Johnson.

Results 1 - 20 of 1,982 in Johnson and Johnson

  1. Dividend Growth Investing FAQRead the original story w/Photo

    7 hrs ago | Seeking Alpha

    There are probably many new readers on Seeking Alpha that have heard about dividends and dividend growth investing, but who do not really know much about the topic. The following is provided as a primer on dividend growth investing.

    Comment?

  2. Lupin Appeals Fine Imposed by European Commission in "Pay-For-Delay" CrackdownRead the original story w/Photo

    Yesterday | jdsupra.com

    In July of this year, the European Commission imposed fines on French pharmaceutical company Servier and five generic drug makers, including Lupin Ltd., totaling 427.7 million. The fines were the result of a five-year investigation into alleged anticompetitive agreements that prevented generic versions of perindopril, Servier's best-selling blood pressure medication, from entering the market.

    Comment?

  3. Drugmakers Rush to Test New Ebola VaccinesRead the original story w/Photo

    17 hrs ago | Bad Astronomy Blog

    While developing drugs to cure Ebola is crucial to end the current epidemic, a vaccine that prevents the infection altogether is the end-game for viral outbreaks - a way to protect healthcare workers on the front lines and to prevent future outbreaks. It typically takes 10 or 20 years to develop and test a vaccine and get it to market.

    Comment?

  4. More Read the original story

    19 hrs ago | KLKN

    This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.

    Comment?

  5. Johnson & Johnson to Host Fourth-Quarter/Full-Year 2014 Investor Conference Call on ResultsRead the original story

    20 hrs ago | DVDCreation Reviews

    At Johnson & Johnson's website: www.investor.jnj.com . This earnings webcast is optimized for mobile streaming on iOS devices such as iPhones, iPods, and iPads.

    Comment?

  6. Health Care Equipment & Supplies in the Netherlands - New Study ReleasedRead the original story

    20 hrs ago | PR-inside.com

    Health Care Equipment & Supplies in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size . The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

    Comment?

  7. "Mexico Traditional Wound Management Market Outlook to 2020" now available at Fast Market ResearchRead the original story

    20 hrs ago | PR-inside.com

    The report provides value, in millions of US dollars, volume and average prices within market segments - Gauzes and Non-Woven Gauzes ), Sponges and Non-Woven Sponges ), Bandages , Non-Adherent Bandages and Adhesive Bandages), Abdominal Pads and Gauze Sponges and Non-Woven Gauze Sponges ). Full Report Details at - ..

    Comment?

  8. "OTC Pharmaceuticals in the Czech Republic" now available at Fast Market ResearchRead the original story

    20 hrs ago | PR-inside.com

    The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Czech Republic otc pharmaceuticals market.

    Comment?

  9. Halozyme Therapeutics, Inc. Strikes $571 Million R&D Pact With Johnson & JohnsonRead the original story

    Yesterday | BioSpace

    December 17, 2014 By Riley McDermid , BioSpace.com Breaking News Editor Shares of enzyme biotech Halozyme Therapeutics were up almost 7 percent in morning trading Wednesday, after the company said that it had signed a deal with pharma behemoth Johnson & Johnson to rent its drug delivery platform for $581 million. Under the terms of the deal, J&J subsidiary Janssen Biotech will pay $15 million up front, with an additional $566 million on tap in milestone payments plus royalties on any approved therapies.

    Comment?

  10. Inovio Pharmaceuticals Appoints Vice President, Clinical Development, OncologyRead the original story

    Yesterday | BioSpace

    In this position, he will be responsible for advancing Inovio's oncology portfolio of DNA immunotherapies through clinical trials to commercialization. He will report to Dr. Inovio is planning a phase III trial for its immunotherapy for a pre-cancer, known as cervical dysplasia, which met its endpoints in a recent phase II trial.

    Comment?

  11. New Market Research Report: Health Care Equipment & Supplies in FranceRead the original story

    21 hrs ago | PR-inside.com

    Health Care Equipment & Supplies in France industry profile provides top-line qualitative and quantitative summary information including: market size . The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

    Comment?

  12. Can Multinationals Innovate In China?Read the original story w/Photo

    21 hrs ago | Forbes.com

    Looking ahead to China's next 30 years of development, CEIBS is committed to creating and sharing the knowledge needed for business leaders, in and outside of China, who will be at the forefront of that growth. From our campuses in the country's financial and political capitals, Shanghai and Beijing, our operations in the bustling southern city of Shenzhen and in Ghana's capital Accra, we connect the dots between China and the rest of the world.

    Comment?

  13. Johnson & Johnson: PAS-X V3 Update at One of the Worldwide Most Important J&J SitesRead the original story

    Wednesday Dec 10 | ThomasNet

    Plant in Geel, Belgium, updated to Werum's PAS-X V3.1.5 / Key role for manufacturing of important chemical APIs / EBR with mobile end devices Lneburg, Germany The multinational pharmaceutical and consumer goods manufacturer Johnson Johnson updated their site in Geel, Belgium, to PAS-X V3.1.5. The Geel site plays a key role for Johnson & Johnson: In this plant, the company manufactures important active pharmaceutical ingredients, for instance for cancer medication, that are then processed further in other facilities around the globe. "Johnson & Johnson has already implemented Werum's PAS-X in some plants," says Anje Vermeiren, Senior Manager Manufacturing Systems of Johnson & Johnson.

    Comment?

  14. Shop Holiday: Grab these gifts for your favorite book loverRead the original story w/Photo

    Yesterday | Pittsburgh Post-Gazette

    As 2015 approaches, it's a relief to know that books - the bound, printed-on-paper kind - are still with us. While we include e-books in this year's holiday gift list, there is something so special about books - their touch, their heft, even their smell.

    Comment?

  15. GlobalData: Top 30 Pharma Companies Spent $112B on R&D in 2013Read the original story w/Photo

    Tuesday | Pharmaceutical Processing

    The world's leading 30 pharmaceutical companies spent a combined $112 billion on research and development in 2013, an increase of $723 million over the previous year, according to research and consulting firm GlobalData. The company's report* states that Roche was the R&D spending leader, outlaying nearly $10 billion in 2013.

    Comment?

  16. Bots Could Cost Marketers $6.3 Billion in 2015Read the original story

    Tuesday | Response

    NEW YORK Advertisers could lose $6.3 billion to bots in 2015 if current fraud rates continue, says new research from the Association of National Advertisers and White Ops, an ad fraud detection firm. Nearly a quarter of all video ads and 11 percent of display ads are served to bots.

    Comment?

  17. Amgen: Assessing The Split Up ValueRead the original story w/Photo

    Tuesday | Seeking Alpha

    Dan Loeb's Third Point hedge fund is a small owner of Amgen , but it has big plans. He thinks the biotech company should split itself into two businesses.

    Comment?

  18. Report Published: "OTC Pharmaceuticals in Mexico"Read the original story

    Tuesday | PR-inside.com

    OTC Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market size . The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

    Comment?

  19. Recent Study: North America Traditional Wound Management Market Outlook to 2020Read the original story

    Tuesday | PR-inside.com

    The report provides value, in millions of US dollars, volume and average prices within market segments - Gauzes and Non-Woven Gauzes ), Sponges and Non-Woven Sponges ), Bandages , Non-Adherent Bandages and Adhesive Bandages), Abdominal Pads and Gauze Sponges and Non-Woven Gauze Sponges ). Full Report Details at - ..

    Comment?

  20. "Health Care Equipment & Supplies in Belgium" PublishedRead the original story

    Tuesday | PR-inside.com

    The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Belgium health care equipment & supplies market.

    Comment?